Trump's latest tariffs on pharmaceuticals may raise US healthcare costs but won't immediately impact Indian drug exports due to a lack of local substitutes. Meanwhile, the success of tech giants like Google and Tesla in India highlights the limitations of Trump's protectionist vision in a global economy, questioning the long-term viability of his economic strategy.